{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:02:28Z","timestamp":1761058948008},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"S1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":9374,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The International Journal of Cell Cloning"],"published-print":{"date-parts":[[1990]]},"DOI":"10.1002\/stem.5530080723","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T11:20:50Z","timestamp":1246533650000},"page":"249-261","source":"Crossref","is-referenced-by-count":6,"special_numbering":"supplement S1","title":["Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy"],"prefix":"10.1093","volume":"8","author":[{"given":"Gary","family":"Spitzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Deisseroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundar","family":"Jagannath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Huan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Dunphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Dicke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Lemaistre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Spinolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1002\/stem.5530080723-BIB1|cit1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.7326\/0003-4819-96-2-139","article-title":"Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease","volume":"96","author":"Santoro","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1002\/stem.5530080723-BIB2|cit2","first-page":"23","article-title":"Third-line salvage chemotherapy in Hodgkin's disease","volume":"12","author":"Bonadonna","year":"1985","journal-title":"Semin Oncol"},{"key":"10.1002\/stem.5530080723-BIB3|cit3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1987.5.4.556","article-title":"MIME chemotherapy (methylgag, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease","volume":"5","author":"Hagemeister","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1002\/stem.5530080723-BIB4|cit4","first-page":"80","article-title":"Combination chemotherapy for the treatment of Hodgkin's disease in relapse: results with lomustine (CCNU), melphalan (alkaran), and vindesine (DVA) alone (CAD) and in alteration with MOPP and doxorubicin (adriamycin), bleomycin, and vinblastine (ABV)","volume":"11","author":"Strauss","year":"1983","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/stem.5530080723-BIB5|cit5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7326\/0003-4819-104-2-163","article-title":"High-dose cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation for relapsed Hodgkin's disease","volume":"104","author":"Jagannath","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1002\/stem.5530080723-BIB6|cit6","first-page":"217","volume-title":"Updated results of CBV and autologous bone marrow transplantation for Hodgkin's disease","author":"Jagannath","year":"1987"},{"key":"10.1002\/stem.5530080723-BIB7|cit7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.1989.7.2.179","article-title":"Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease","volume":"7","author":"Jagannath","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1002\/stem.5530080723-BIB8|cit8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.1986.4.1.4","article-title":"High-dose intensification therapy with autologous bone marrow support for limited small cell bronchogenic carcinoma","volume":"4","author":"Spitzer","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1002\/stem.5530080723-BIB9|cit9","first-page":"245","volume-title":"Bone Marrow Transplantation: Current Controversies","volume":"91","author":"Dunphy","year":"1989"},{"key":"10.1002\/stem.5530080723-BIB10|cit10","first-page":"399","volume-title":"Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium","author":"Spitzer","year":"1989"},{"key":"10.1002\/stem.5530080723-BIB11|cit11","first-page":"405","volume-title":"Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium","author":"Dunphy","year":"1989"},{"key":"10.1002\/stem.5530080723-BIB12|cit12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.V55.2.317.317","article-title":"The myeloid progenitor cell-its value in predicting hematopoietic recovery after autologous bone marrow transplantation","volume":"55","author":"Spitzer","year":"1980","journal-title":"Blood"},{"key":"10.1002\/stem.5530080723-BIB13|cit13","unstructured":"Taylor K Jaganath S Spitzer G J Clin Oncol 1989"},{"key":"10.1002\/stem.5530080723-BIB14|cit14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2141.1984.tb03987.x","article-title":"High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation","volume":"58","author":"To","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1002\/stem.5530080723-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood.V47.6.1031.1031","article-title":"Increase in circulating stem cells following chemotherapy in man","volume":"47","author":"Richman","year":"1976","journal-title":"Blood"},{"key":"10.1002\/stem.5530080723-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0140-6736(88)92012-0","article-title":"Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man","volume":"i","author":"Socinski","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/stem.5530080723-BIB17|cit17","volume-title":"The in vivo effect of granulocyte-macrophage colony stimulating factor on circulating progenitor cells in man","author":"Socinski","year":"1989"},{"key":"10.1002\/stem.5530080723-BIB18|cit18","volume-title":"Very rapid and complete hemopoietic reconstitution following myeloablative treatments: the role of circulating stem cells harvested after high-dose cyclophosphamide and GM-CSF","author":"Gianni","year":"1989"},{"key":"10.1002\/stem.5530080723-BIB19|cit19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198804073181401","article-title":"Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation","volume":"318","author":"Brandt","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1002\/stem.5530080723-BIB20|cit20","first-page":"49","article-title":"GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease","volume":"4","author":"Devereaux","year":"1989","journal-title":"Bone Marrow Transplantation"}],"container-title":["The International Journal of Cell Cloning"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.5530080723","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/stem.5530080723\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T15:01:11Z","timestamp":1651849271000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/8\/S1\/249-261\/6386610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"references-count":20,"journal-issue":{"issue":"S1"},"URL":"https:\/\/doi.org\/10.1002\/stem.5530080723","relation":{},"ISSN":["0737-1454","1549-4918"],"issn-type":[{"value":"0737-1454","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990]]}}}